MAA
BIO icon

Managed Account Advisors’s Bio-Rad Laboratories Class A BIO Stock Holding History

Managed Account Advisors’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		$40M Sell
265,360
-16,646
-6% -$2.38M 0.03% 483
2015
Q1 		$38.1M Sell
282,006
-4,804
-2% -$595K 0.03% 483
2014
Q4 		$34.6M Sell
286,810
-5,780
-2% -$665K 0.03% 490
2014
Q3 		$33.2M Sell
292,590
-3,840
-1% -$455K 0.04% 484
2014
Q2 		$35.5M Buy
296,430
+764
+0.3% +$93.3K 0.04% 449
2014
Q1 		$37.9M Sell
295,666
-1,339
-0.5% -$172K 0.05% 408
2013
Q4 		$36.7M Buy
297,005
+5,925
+2% +$722K 0.05% 411
2013
Q3 		$34.2M Buy
291,080
+4,469
+2% +$527K 0.05% 403
2013
Q2 		$32.2M Buy
+286,611
New +$33.6M 0.05% 401

Other funds holding BIO

ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
LCS
Levin Capital Strategies New York $1.32B AUM 28.11% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return